Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,942 | 309 | 78 | 0 | 0 |
| Receivables | 29 | 31 | 35 | 0 | 0 |
| TOTAL | $6,109 | $447 | $170 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 19 | 22 | 24 | N/A | N/A |
| Intangibles | 1,048 | 1,079 | 1,109 | 0 | 0 |
| Other Non-Current Assets | 30 | 1,253 | 911 | 0 | 0 |
| TOTAL | $1,097 | $2,353 | $2,045 | $N/A | $N/A |
| Total Assets | $7,206 | $2,800 | $2,215 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,361 | 1,502 | 1,451 | 0 | 0 |
| Accrued Expenses | 1,185 | 780 | 924 | 0 | 0 |
| TOTAL | $2,546 | $2,431 | $2,920 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 16,006 | 10,322 | 0 | 0 |
| TOTAL | $49 | $16,109 | $10,425 | $N/A | $N/A |
| Total Liabilities | $2,595 | $18,541 | $13,345 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13 | 7 | N/A | N/A | N/A |
| Retained earnings | -45,313 | -40,267 | -35,520 | 0 | 0 |
| TOTAL | $4,611 | $-15,741 | $-11,131 | $0 | $0 |
| Total Liabilities And Equity | $7,206 | $2,800 | $2,215 | $0 | $0 |